Link Matthew, Chief Commercial Officer at Sight Sciences, Inc. ($SGHT), made two open market sales of company shares over the past year, totaling $31,677. His most recent sale occurred on July 2, 2025. These sales rank 10,769th among 11,678 individual insiders, compared to an average sale value of $8.6 million and 6 sales per insider. Link Matthew had no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2025 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 4889 | $4.10 | 832,293.0000 | 51,332,694 | 0.58% | 0.01% |
| June 12, 2025 | FibroBiologics, Inc. | $FBLG | Link Matthew | Director | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 37,735,300 | 9999.99% | 0.06% |
| May 16, 2025 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | A | Common Stock | 6631 | $3.02 | 837,182.0000 | 51,332,694 | 0.80% | 0.01% |
| April 2, 2025 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 5042 | $2.31 | 830,551.0000 | 51,332,694 | 0.60% | 0.01% |
| March 11, 2025 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | A | Common Stock | 172043 | $0.00 | 835,593.0000 | 51,332,694 | 25.93% | 0.34% |
| Oct. 21, 2024 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 21831 | $5.61 | 663,550.0000 | 0 | 3.19% | 0.00% |
| Oct. 18, 2024 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 20487 | $5.98 | 685,381.0000 | 0 | 2.90% | 0.00% |
| Oct. 16, 2024 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 20734 | $5.91 | 726,838.0000 | 0 | 2.77% | 0.00% |
| Oct. 17, 2024 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | S | Common Stock | 20970 | $5.84 | 705,868.0000 | 0 | 2.89% | 0.00% |
| Aug. 27, 2024 | FibroBiologics, Inc. | $FBLG | Link Matthew | Director | A | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2023 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | A | Common Stock | 747572 | $0.00 | 747,572.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2023 | Sight Sciences, Inc. | $SGHT | Link Matthew | Chief Commercial Officer | A | Stock Option (Right to Buy) | 526430 | $0.00 | 526,430.0000 | 0 | 9999.99% | 0.00% |